Stakeholders ask FDA to harmonize adverse events terms with standards orgs
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and DevelopmentRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development